nir hus md, phd., absite review q11
DESCRIPTION
Slides with topics that are covered and were tested in the recent Absite exams.Nir Hus MD., PhD.http://www.nirhus.comTRANSCRIPT
![Page 1: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/1.jpg)
Absite Topic Review General Surgery
Nir Hus, MD, PhD. Mount Sinai Medical Center Miami Beach
![Page 2: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/2.jpg)
Transplantation
![Page 3: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/3.jpg)
Q1 – Two weeks s/p renal transplant, a pt. developes res. Insufficiency requiring adm. To ICU. CXR shows diffuse infiltrates & BAL show cells w/ inclusion bodies. The most appropriate therapy is:
A. Gangcyclvir B. Acyclovir C. Bactrim D. PCN
![Page 4: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/4.jpg)
Q2 – Hyperacute rejection following organ trans. Is most often due:
A. ABO incompatibility B. Rh incompatibility C. Previously sensitized T cells D. Macrophages
![Page 5: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/5.jpg)
Q3 – Hyperacute rejection is an example of hypersensitivity reaction type:
A. Type I B. Type II C. Type III D. Type IV
![Page 6: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/6.jpg)
Q4 – Successful Tx of hyperacute rejection usually involves
A. Steroids B. Removal of the organ & re-trans. C. OKT3 D. Rapamycin
![Page 7: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/7.jpg)
Q5 – The machanism of cyclosporin is:
A. Binds FK binding protein B. Binds cyclophilin protein C. Inhibits purine synthesis by way of 6-
mercaptopurine intermidiate. D. Binds antigen on T cells
![Page 8: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/8.jpg)
Q6 - The mechanism of azathioprine is:
A. Binds FK binding protein B. Binds cyclophilin protein C. Inhibits purine synthesis by way of 6-
mercaptopurine intermidiate. D. Binds antigen on T cells
![Page 9: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/9.jpg)
Q7 – The most common malignancy following transplantation is:
A. Lung CA B. Prostate CA C. Breast CA D. Skin CA
![Page 10: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/10.jpg)
Q8 – A positive cross-match means:
A. There are no immunologic problems so one may proceed w/ the trans.
B. Will likely result in only mild rejection sometimes after the 1st week.
C. The recipient has preformed AB to donor Ag. D. Both the donor and recipient are CMV positive.
![Page 11: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/11.jpg)
Q9 – A cross-match is performed by:
A. Mixing donor lymphocytes w/ recipient serum
B. Mixing recipient lymphocytes w/ donor serum
C. Mixing donor plasma w/ recipient serum D. Mixing recipient plasma w/ donor serum.
![Page 12: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/12.jpg)
Q10 – Post-transplant lymphoproliferative disorder has been most commonly linked to:
A. HSV B. RSV C. EBV D. Influenza viruses
![Page 13: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/13.jpg)
Q11 - A 35 yo man POD#6 from a cadaveric renal trans. Developes a rise in Cr. The most appropriate next step is:
A. Emergent reop B. Angiography C. OKT3 D. US
![Page 14: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/14.jpg)
Q12 – in the previous pt. the US shows flow acceleration of the renal artery. The next appropriate step is:
A. Emergent reop B. Angiography C. OKT3 D. US
![Page 15: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/15.jpg)
Q13 – in the previous pt. the US is normal. The next appropriate step is:
A. Emergent reop B. Angiography C. OKT3 D. Biopsy
![Page 16: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/16.jpg)
Q14 - in the previous pt. the Bx. shows acute tubulitis. This is consistent w/:
A. Acute rejection B. UTI C. Chronic rejection D. Renal vein thrombosis.
![Page 17: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/17.jpg)
Q15 – New proteinnuria in a pt. following renal trans. Is most consistent w/:
A. Acute rejection B. UTI C. Chronic rejection D. Renal vein thrombosis.
![Page 18: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/18.jpg)
Q16 – Most common cause of acute death in a living related renal trans. Is:
A. PE B. Hemorrhage C. MI D. Infection
![Page 19: Nir Hus MD, PhD., Absite review q11](https://reader035.vdocuments.mx/reader035/viewer/2022081907/54720b49b4af9fa30a8b4df3/html5/thumbnails/19.jpg)
Q17 – Most common cause of acute death following renal trans. In a recipient is:
A. PE B. Hemorrhage C. MI D. Infection